Exhibit 99.6

Handa Lab Co., Ltd. and Subsidiary

Condensed Consolidated Interim Financial Statements

(Unaudited)

As of September 30, 2025 and for the nine-month periods ended September 30, 2025 and 2024

Table of Contents

Handa Lab Co., Ltd. and Subsidiary

Unaudited Condensed Consolidated Balance Sheets

(in US dollars)

See accompanying notes to the unaudited condensed consolidated interim financial statements.

Handa Lab Co., Ltd. and Subsidiary

Unaudited Condensed Consolidated Balance Sheets, Continued

(in US dollars)

See accompanying notes to the unaudited condensed consolidated interim financial statements.

Handa Lab Co., Ltd. and Subsidiary

Unaudited Condensed Consolidated Interim Statements of Operations

(in US dollars)

See accompanying notes to the unaudited consolidated interim financial statements.

Handa Lab Co., Ltd. and Subsidiary

Unaudited Condensed Consolidated Statements of Comprehensive Loss

(in US dollars)

See accompanying notes to the unaudited consolidated interim financial statements.

Handa Lab Co., Ltd. and Subsidiary

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity

(in US dollars)

See accompanying notes to the unaudited consolidated interim financial statements.

Handa Lab Co., Ltd. and Subsidiary

Unaudited Condensed Consolidated Interim Statements of Cash Flows

(in US dollars)

See accompanying notes to the unaudited consolidated interim financial statements.

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements

1. Summary of Significant Accounting Policies

Handa Lab Co., Ltd. (the “Company”) and subsidiary (collectively, the “Group”), established in 2021, specialize in the manufacture and sale of intelligent monitoring systems, machine vision and laser testing systems, data gathering systems. The Company offers a diverse range of equipment and software, tailored to meet specific customer requirements in terms of specifications, functions, standards, and delivery timelines. Handa Corporation Co., Ltd., in which the Company holds a 60% stake, was established in 2023 and specializes in the manufacture and sale of intelligent robotic systems.

These financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) assuming the Group will continue as a going concern. The accounting policies applied by the Group in these consolidated interim financial statements are the same as those applied by the Group in its condensed consolidated financial statements as of and for the year ended December 31, 2024.

The unaudited condensed interim financial information does not represent complete financial statements and should be read in conjunction with the Group’s latest annual audited financial statements.

These interim results are not necessarily indicative of the results to be expected for the fiscal year ended December 31, 2025, or for any other interim period or for any other future year.

In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Group’s financial information.

The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, substantial doubt about the Group’s ability to continue as going concern exists.

Primarily due to a decline in sales associated with the business, the Group generated loss for the period of $311,125 and net cash outflows from operations of $213,915 for the period ended September 30, 2025. At September 30, 2025, however, the Group had a net working capital of $43,811 and cash equivalents of $641,095.

The Group is evaluating strategies to obtain the required additional funding for future operations. These strategies may include, but are not limited to, obtaining equity financing, issuing debt or entering into other financing arrangements, and restructuring of operations to grow revenues and decrease expenses. However, upon the economic environment and the Group’s current capability, the Group may be unable to access future equity or debt financing when needed. As such, there can be no assurance that the Group will be able to obtain additional liquidity when needed or under acceptable terms, if at all.

The condensed consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Group were unable to continue as a going concern.

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

Income Statement (Topic 220) Reporting Comprehensive Income - Expense Disaggregation Disclosures

In November 2024, the FASB issued ASU 2024-03, which becomes effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The standard requires to disclose disaggregated information about certain income statement expense line items. The Group does not expect the standard to have a material effect on its financial statements and has begun evaluating disclosure presentation alternatives.

Income Taxes (Topic 740) - Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The ASU requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. The Group does not expect the standard to have a material effect on its financial statements.

The Group has not early adopted any of the forthcoming new or amended accounting standards in preparing these condensed consolidated interim financial statements.

The Group manufactures smart monitoring visual system and laser inspection systems. The specifications, functions, and delivery dates vary depending on the demand of customers. After receiving orders from customers, the Group manufactures and sell those products.

The Group’s operating segment is a single segment and compose of equipment and machine manufacturing segment, and as of the end of the reporting period, assets and liabilities of the segment is the same as the attached financial statements. The manufacturing periods vary per project, ranging from as short as one month to over a year. Sales are approximately $196 thousand in the third quarter of 2025, all of which are domestic.

Sales to a small number of major customers account for all of the Group’s total net revenue. The Group is making efforts to gain new customers by continuously expanding its sales activities. If orders from existing major customers decrease, there is a possibility of a loss of sales, which may adversely affect business results.

For the nine-month period ended September 30, 2025, the customers accounting for 10% or more of total revenue are Customer D, Customer F and Customer A, with revenues of $57,022, $31,993 and $27,363, respectively. For the nine-month period ended September 30, 2024, the customers accounted for 10% or more of Total revenue are Customer B and Customer C, with revenues of $85,301 and $80,497, respectively.

The following table disaggregates trade accounts receivable and contracts assets by major customers.

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

There was no allowance for credit losses related to trade accounts receivables recorded as of September 30, 2025 and December 31, 2024.

Non-trade account receivables consist of accrued income and refundable tax. The Group disaggregates the non-trade account receivable by type of financing receivable when assessing and monitoring risk and performance of the entire portfolio.

Non-trade account receivables are unsecured and generally have terms of less than one year, requiring payments of principal at maturity.

The amortized cost basis of non-trade account receivable, net as of September 30, 2025 and December 31, 2024, respectively, was as follows:

There was no allowance for credit losses related to non-trade account receivables recorded as of September 30, 2025 and December 31, 2024.

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

Details of inventories as of September 30, 2025 and December 31, 2024 were as follows:

There were no write-downs of inventories recorded for the period ended September 30, 2025 and December 31, 2024.

Total depreciation for the nine-month periods ended September 30, 2025 and 2024 was $14,791 and $7,897, respectively.

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

The Group has operating leases for corporate offices and certain office equipment. Operating lease assets and liabilities are included in operating lease right-of-use assets and operating lease liabilities, respectively, on the condensed consolidated balance sheets.

Lease agreement of office space include renewal options for up to 10 years, renewable annually under the Commercial Building Lease Protection Act in Korea. Because the Group is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and associated potential option payments are excluded from lease payments.

The Group’s leases generally do not include termination options for either party to the lease or restrictive financial or other covenants. Payments due under the lease contracts include fixed payments.

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

Details of the carrying amounts of long-term debt as of September 30, 2025 and December 31, 2024 were as follows:

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

The Company is subject to income taxation primarily in South Korea, and we do not expect any income tax expenses for the nine-month period ended September 30, 2025 and 2024, including tax expenses directly recorded in equity.

There were no unrecognized tax benefits as of September 30, 2025 and December 31, 2024.

The Company has 1,500 thousand shares of authorized stock, consisting of: common stock, par value KRW 5,000 (equivalent to $ 3.70) per share, issuable. As of September 30, 2025, there were 380,800 shares of common stock outstanding. In 2024, a total of 89,000 shares were increased through a paid-in capital increase.

Common Stock

Holders of common stock are entitled to one vote per share, and to receive dividends and, upon liquidation or dissolution, are entitled to receive all assets available for distribution to stockholders. The holders have no preemptive or other subscription rights, and there is no redemption or sinking fund provisions with respect to such shares.

The Group has a defined contribution plan. Under this plan, the Group pays specified amounts of contributions into a separate fund. These contributions are recognized as expenses when they are paid. The expenses related to post-retirement benefit plans under the defined contribution plans for the nine-month periods ended September 30, 2025 and 2024 were as follows:

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

Handa Lab Co., Ltd. and Subsidiary

Notes to the Unaudited Condensed Consolidated Interim Financial Statements, Continued

As of September 30, 2025, the Group has evaluated its commitments and contingencies and determined that no material commitments or contingencies exist.

The Group has evaluated subsequent events from the balance sheet date to the date at which the unaudited condensed consolidated interim financial statements were available to be issued, and except as disclosed below, no other events requiring disclosure were identified.